Mallinckrodt Deutschland GmbH
2 products tracked · names used in filings: Mallinckrodt Deutschland GmbH, Mallinckrodt Pharmaceuticals Ireland Limited
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Raplixa human fibrinogen;human thrombin | Withdrawn | 2015-03-19 |
| 🇪🇺 | Optimark gadoversetamide | Withdrawn | 2007-07-23 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.